Customer Success

As specialists in droplet microfluidic screening, we evaluated multiple technologies and identified the ModaFlow platform as the most efficient in terms of sample economy, usability, and reproducibility. The instrument is highly intuitive to operate, and it consistently delivers reliable, high‑quality results. To date, we have successfully applied the system for hydrogel droplet generation within the context of compound library screening. Furthermore, the customer service and application support teams have been very responsive, knowledgeable, and quick to address all our questions. Overall, we are extremely satisfied with the platform and the support provided.

Evelien Mathieu

PhD, Senior Scientist Lead Characterization

Sanofi

At Cellistic, we are committed to advance allogeneic cell therapy using iPSC. Our iPSC allogeneic cell therapy platforms Pulse and Echo are build using state of the art technology. To advance our capabilities further we are thrilled to work with LiveDrop’s advanced microfluidic technology. This technology has several benefits and perfectly aligns with our mission to make cell therapies more accessible and affordable. By enhancing cell line development precision and accelerating manufacturing processes, we are reinforcing our commitment to delivering cutting-edge cell therapy solutions with greater efficiency.

Stefan Braam

Founder and CTO

Cellistic

Droplet microfluidics integrated with LiveDrop’s advanced bioassays is revolutionizing immunology research. These tools enable high-throughput B-cell screening (sequencing?), monoclonal antibody discovery, and single-cell antibody response studies with unmatched precision. A game-changer technology to support innovation in Life Sciences. By rapidly screening plasma cells and Fc receptor interactions, LiveDrop drive breakthroughs in autoimmune and allergy therapies, transforming our understanding of human immunity.

Adrien Boes

PhD

CER Group, Belgium

Thank you again for the LiveDrop demo last week. We greatly appreciated the overall experience! Fast priming protocol and robustness of the priming method - Easy recovery of the generated emulsion - Low dead volume - Real-time visual monitoring of the droplet generation process I greatly appreciated the expertise of both colleagues, as well as their dedication to adapt to our needs and planned experiments. Explanations were always clear and detailed.

Heshuang Qu

PhD Post doc researcher

Karolinska Institute - Sweden